Alkermes (ALKS) Net Income (2010 - 2026)
Alkermes (ALKS) recorded Net Income of $16.29 million in Q3 2026, down 80.3% from $82.76 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) Net Income (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' Net Income came in at -$351,000 as of Sep 30, 2026; for FY2025, it came in at $241.66 million, down 34.2% from FY2024.
- Across earlier years, Net Income came in at $367.07 million in FY2024 (+3.2%), $355.76 million in FY2023, -$158.27 million in FY2022 and -$48.17 million in FY2021.
- Quarterly Net Income has ranged from -$66.48 million in Q1 2026 to $237.07 million in Q2 2023 over the past five years.
- On a year-over-year basis, Net Income rose in 1 of the last seven quarters, with an average decline of 38.6%.
- Peak year-over-year performance for Net Income in the last five years was growth of 93.4% in Q3 2024, against a decline of 99.4% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $501,000 (Q2 2026), -$66.48 million (Q1 2026) and $49.34 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 16.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.29 Mn |
| Jun 30, 2026 | 501,000.00 |
| Mar 31, 2026 | -66.48 Mn |
| Dec 31, 2025 | 49.34 Mn |
| Sep 30, 2025 | 82.76 Mn |
| Jun 30, 2025 | 87.10 Mn |
| Mar 31, 2025 | 22.46 Mn |
| Dec 31, 2024 | 146.50 Mn |
| Sep 30, 2024 | 92.38 Mn |
| Jun 30, 2024 | 91.36 Mn |
| Mar 31, 2024 | 36.83 Mn |
| Dec 31, 2023 | 112.78 Mn |
| Sep 30, 2023 | 47.76 Mn |
| Jun 30, 2023 | 237.07 Mn |
| Mar 31, 2023 | -41.85 Mn |
| Dec 31, 2022 | -28.25 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 873,000.00 |
API Access
Alkermes Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();